Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2018 Nov;46(11):4465-4471.
doi: 10.1177/0300060518794245. Epub 2018 Sep 10.

Efficacy and safety of yttrium-aluminium garnet (YAG) laser vitreolysis for vitreous floaters

Affiliations
Clinical Trial

Efficacy and safety of yttrium-aluminium garnet (YAG) laser vitreolysis for vitreous floaters

Jihan Luo et al. J Int Med Res. 2018 Nov.

Abstract

Objective: To examine the efficacy and safety of yttrium-aluminium garnet (YAG) laser vitreolysis for the treatment of vitreous floaters.

Methods: Consecutive adult patients with symptomatic vitreous floaters who attended Chongqing General Hospital from April to December 2016 were included in this prospective study. Patients had >3 mm between the vitreous opacity and retina/lens and acceptable quality peri-papillary Optical Coherence Tomography (OCT) images (i.e., signal strength ≥5). Those with history of glaucoma, severe cataracts, vitreous haemorrhages, retinal holes and/or macular disease were excluded from the study. Best corrected visual acuity (BCVA) and non-contact intraocular pressure (IOP) were measured before and for up to 6 months post-YAG laser vitreolysis. Anterior segment photography and peripapillary retinal nerve fibre layer (RNFL) measured by OCT were taken before and 6 months post-procedure. Questionnaires on patient satisfaction were completed 6 months post-procedure.

Results: No statistically significant differences in BCVA and IOP were observed before or after treatment. Anterior segment photography showed that vitreous opacities partially or completely disappeared after YAG laser treatment. The thickness of RNFL in four directions (upper, below, nasal and temporal) was not statistically significant different before or 6 months after the procedure. 75% patients reported significant improvement and 25% reported moderate improvement.

Conclusion: The results of this study conducted in a cohort of 30 Chinese patients showed that YAG laser vitreolysis was a well-tolerated and effective treatment for vitreous floaters. Randomised, controlled trials involving large numbers of participants monitored over an extended follow up period are required to confirm these results.

Keywords: Yttrium-aluminium Garnet laser vitreolysis; anterior segment photography; optical coherence tomography; peripapillary retinal nerve fibre layer; vitreous floaters.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Anterior segment photography with the aid of a Volk Digital High Mag optic lens before and 6 months after YAG laser treatment. Pre-operative: An irregular ribbon-like opacity in optic axis of vitreous cavity was observed before treatment. Post-operative: Six months after YAG laser treatment the ribbon had disappeared and some cloudy segments remained.

Similar articles

Cited by

References

    1. Sendrowski DP, Bronstein MA. Current treatment for vitreous floaters. Optometry 2010; 81: 157–161. - PubMed
    1. Lumi X, Hawlina M, Glavač D, et al. Ageing of the vitreous: From acute onset floaters and flashes to retinal detachment. Ageing Res Rev 2015, 21: 71–77. - PubMed
    1. Shah CP, Heier JS. YAG Laser vitreolysis vs sham YAG vitreolysis for symptomatic vitreous floaters: a randomized clinical trial. JAMA Ophthalmol 2017; 135:918–923. - PMC - PubMed
    1. Shaimova VA, Shaimov TB, Shaimov RB, et al. Evaluation of YAG-laser vitreolysis effectiveness based on quantitative characterization of vitreous floaters. Vestn Oftalmol 2018, 134: 56–62. [Article in Russian] - PubMed
    1. Nishiguchi K. Functional regulation of heparin-binding proteins and maintenance of vitreal transparency by intravitreal glucosaminoglycan. Nihon Ganka Gakkai Zasshi 2012; 116: 1052–1061. - PubMed

Publication types